Home > Insider Trading > Filing (0001209191-22-036001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490829	James Jones	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-05-02	30	$2.45	20,713	No	4	P	Direct
Common Stock	Acquisiton	2022-05-03	30	$2.42	20,743	No	4	P	Direct
Common Stock	Acquisiton	2022-05-04	30	$2.37	20,773	No	4	P	Direct
Common Stock	Acquisiton	2022-05-05	30	$2.35	20,803	No	4	P	Direct
Common Stock	Acquisiton	2022-05-06	30	$2.36	20,833	No	4	P	Direct
Common Stock	Acquisiton	2022-05-09	34	$2.63	20,867	No	4	P	Direct
Common Stock	Acquisiton	2022-05-10	34	$2.55	20,901	No	4	P	Direct
Common Stock	Acquisiton	2022-05-11	34	$2.37	20,935	No	4	P	Direct
Common Stock	Acquisiton	2022-05-12	34	$2.23	20,969	No	4	P	Direct
Common Stock	Acquisiton	2022-05-13	34	$2.32	21,003	No	4	P	Direct
Common Stock	Acquisiton	2022-05-16	34	$2.31	21,037	No	4	P	Direct
Common Stock	Acquisiton	2022-05-17	34	$2.35	21,071	No	4	P	Direct
Common Stock	Acquisiton	2022-05-18	34	$2.31	21,105	No	4	P	Direct
Common Stock	Acquisiton	2022-05-19	34	$2.29	21,139	No	4	P	Direct
Common Stock	Acquisiton	2022-05-20	34	$2.23	21,173	No	4	P	Direct
Common Stock	Acquisiton	2022-05-23	38	$2.17	21,211	No	4	P	Direct
Common Stock	Acquisiton	2022-05-24	38	$2.17	21,249	No	4	P	Direct
Common Stock	Acquisiton	2022-05-25	38	$2.15	21,287	No	4	P	Direct
Common Stock	Acquisiton	2022-05-26	38	$2.12	21,325	No	4	P	Direct
Common Stock	Acquisiton	2022-05-27	38	$2.13	21,363	No	4	P	Direct
Common Stock	Acquisiton	2022-05-31	38	$2.13	21,401	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.